US Stock MarketDetailed Quotes
ANTX AN2 Therapeutics
- 1.670
- +0.300+21.90%
Close Nov 29 13:00 ET
- 1.610
- -0.060-3.59%
Post 16:53 ET
49.90MMarket Cap-839P/E (TTM)
1.675High1.470Low1.32MVolume1.480Open1.370Pre Close2.04MTurnover9.11%Turnover RatioLossP/E (Static)29.88MShares22.22052wk High0.57P/B24.16MFloat Cap0.87052wk Low--Dividend TTM14.47MShs Float23.580Historical High--Div YieldTTM14.96%Amplitude0.870Historical Low1.550Avg Price1Lot Size
AN2 Therapeutics Key Stats
EPS
According to the latest financial report of AN2 Therapeutics, the latest earnings per share (TTM) for the company is -0.43. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about AN2 Therapeutics's free cash flow? The latest report shows it as -12.01M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of AN2 Therapeutics shows that the company's current ratio is 9.75, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of AN2 Therapeutics, the quick ratio is 9.33, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of AN2 Therapeutics? The latest ROE figure is -13.70%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of AN2 Therapeutics, the total asset return on investment (ROA) is -12.37%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check AN2 Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of AN2 Therapeutics, the net profit margin is 5.82%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
